The stock of Zimmer Biomet Holdings Inc (ZBH) has gone down by -3.76% for the week, with a -6.79% drop in the past month and a -0.93% drop in the past quarter. The volatility ratio for the week is 1.60%, and the volatility levels for the past 30 days are 2.03% for ZBH. The simple moving average for the past 20 days is -3.36% for ZBH’s stock, with a -7.79% simple moving average for the past 200 days.
Is It Worth Investing in Zimmer Biomet Holdings Inc (NYSE: ZBH) Right Now?
Zimmer Biomet Holdings Inc (NYSE: ZBH) has a price-to-earnings ratio that is above its average at 19.66x. The stock has a 36-month beta value of 1.02. Opinions on the stock are mixed, with 6 analysts rating it as a “buy,” 4 as “overweight,” 17 as “hold,” and 1 as “sell.”
The public float for ZBH is 198.79M, and at present, short sellers hold a 3.40% of that float. On January 03, 2025, the average trading volume of ZBH was 1.48M shares.
ZBH) stock’s latest price update
Zimmer Biomet Holdings Inc (NYSE: ZBH) has experienced a decline in its stock price by -1.19 compared to its previous closing price of 104.46. However, the company has seen a fall of -3.76% in its stock price over the last five trading days. zacks.com reported 2024-12-26 that Zimmer Biomet is witnessing strong market share gains within reconstructive Knees and Hips in key geographies despite macroeconomic challenges.
Analysts’ Opinion of ZBH
Many brokerage firms have already submitted their reports for ZBH stocks, with JP Morgan repeating the rating for ZBH by listing it as a “Overweight.” The predicted price for ZBH in the upcoming period, according to JP Morgan is $128 based on the research report published on December 17, 2024 of the previous year 2024.
Piper Sandler gave a rating of “Neutral” to ZBH, setting the target price at $115 in the report published on July 01st of the previous year.
ZBH Trading at -4.48% from the 50-Day Moving Average
After a stumble in the market that brought ZBH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.91% of loss for the given period.
Volatility was left at 2.03%, however, over the last 30 days, the volatility rate increased by 1.60%, as shares sank -6.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.03% lower at present.
During the last 5 trading sessions, ZBH fell by -3.79%, which changed the moving average for the period of 200-days by -18.53% in comparison to the 20-day moving average, which settled at $106.81. In addition, Zimmer Biomet Holdings Inc saw -2.28% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZBH starting from Yi Sang, who sale 12,857 shares at the price of $114.69 back on May 31 ’24. After this action, Yi Sang now owns 5,322 shares of Zimmer Biomet Holdings Inc, valued at $1,474,582 using the latest closing price.
Yi Sang, the Group President, Asia Pacific of Zimmer Biomet Holdings Inc, sale 1,705 shares at $126.86 during a trade that took place back on Mar 07 ’24, which means that Yi Sang is holding 18,179 shares at $216,296 based on the most recent closing price.
Stock Fundamentals for ZBH
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.66 for the gross margin
The net margin for Zimmer Biomet Holdings Inc stands at 0.14. The total capital return value is set at 0.08. Equity return is now at value 8.71, with 5.05 for asset returns.
Based on Zimmer Biomet Holdings Inc (ZBH), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.52. The interest coverage ratio of the stock is 6.67.
Currently, EBITDA for the company is 2.21 billion with net debt to EBITDA at 2.39. When we switch over and look at the enterprise to sales, we see a ratio of 3.5. The receivables turnover for the company is 5.13for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.36.
Conclusion
To sum up, Zimmer Biomet Holdings Inc (ZBH) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
